{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:25:21Z","timestamp":1784204721827,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T00:00:00Z","timestamp":1385078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12072-013-9484-6","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T08:10:09Z","timestamp":1385021409000},"page":"83-93","source":"Crossref","is-referenced-by-count":9,"title":["Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients"],"prefix":"10.1007","volume":"8","author":[{"given":"Peter","family":"Ferenci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Aires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Beavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Curescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R.","family":"Abr\u00e3o Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gschwantler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Larrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Maticic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Schuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Tornai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tusn\u00e1di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethelm","family":"Messinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Tatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Horban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,22]]},"reference":[{"key":"9484_CR1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335\u20131374","journal-title":"Hepatology"},{"key":"9484_CR2","unstructured":"Foster G, Roberts S, Pol S, Andreone P, Lawitz E, Younossi Z. Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon\/ribavirin treatment failure: subanalysis of the REALIZE phase 3 study. In: Poster, 22nd conference of the Asian Pacific Association for the Study of the Liver (APASL) Taipei, Taiwan, 16\u201319 Feb 2012"},{"key":"9484_CR3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449\u20131457","journal-title":"Hepatology"},{"key":"9484_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2008.07.039","volume":"50","author":"SH Mehta","year":"2009","unstructured":"Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol 2009;50:36\u201341","journal-title":"J Hepatol"},{"key":"9484_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hep.24671","volume":"55","author":"S Beinhardt","year":"2012","unstructured":"Beinhardt S, Staettermayer AF, Rutter K, Maresch J, Scherzer TM, Steindl-Munda P, et al. Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias? Hepatology 2012;55:30\u201338","journal-title":"Hepatology"},{"key":"9484_CR6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","volume":"142","author":"L Castera","year":"2012","unstructured":"Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293\u20131302","journal-title":"Gastroenterology"},{"key":"9484_CR7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","volume":"53","author":"F Degos","year":"2010","unstructured":"Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010;53:1013\u20131021","journal-title":"J Hepatol"},{"key":"9484_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-230X-10-103","volume":"10","author":"M Friedrich-Rust","year":"2010","unstructured":"Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol 2010;10:103","journal-title":"BMC Gastroenterol"},{"key":"9484_CR9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jinf.2011.07.017","volume":"63","author":"S Resino","year":"2011","unstructured":"Resino S, Asensio C, Bellon JM, Carmona R, Miralles P, Lopez JC, et al. Diagnostic accuracy of the APRI, FIB-4, and the Forns index for predicting liver fibrosis in HIV\/HCV-coinfected patients: a validation study. J Infect 2011;63:402\u2013405","journal-title":"J Infect"},{"key":"9484_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2008.03895.x","volume":"29","author":"V Mallet","year":"2009","unstructured":"Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, Giry C, et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409\u2013415","journal-title":"Aliment Pharmacol Ther"},{"key":"9484_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007;46:32\u201336","journal-title":"Hepatology"},{"key":"9484_CR12","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518\u2013526","journal-title":"Hepatology"},{"key":"9484_CR13","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/hep.25892","volume":"56","author":"P Marcellin","year":"2012","unstructured":"Marcellin P, Cheinquer H, Curescu M, Dusheiko GM, Ferenci P, Horban A, et al. High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials. Hepatology 2012;56:2039\u20132050","journal-title":"Hepatology"},{"key":"9484_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289\u2013293","journal-title":"Hepatology"},{"key":"9484_CR15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 2006;43:1317\u20131325","journal-title":"Hepatology"},{"key":"9484_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495\u2013500","journal-title":"N Engl J Med"},{"key":"9484_CR17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.22085","volume":"47","author":"M Adler","year":"2008","unstructured":"Adler M, Gulbis B, Moreno C, Evrard S, Verset G, Golstein P, et al. The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns Index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases. Hepatology 2008;47:762\u2013763","journal-title":"Hepatology"},{"key":"9484_CR18","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.3748\/wjg.v16.i45.5710","volume":"16","author":"RR Mummadi","year":"2010","unstructured":"Mummadi RR, Petersen JR, Xiao SY, Snyder N. Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol 2010;16:5710\u20135715","journal-title":"World J Gastroenterol"},{"key":"9484_CR19","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1007\/s10620-011-1710-2","volume":"56","author":"AG Shah","year":"2011","unstructured":"Shah AG, Smith PG, Sterling RK. Comparison of FIB-4 and APRI in HIV\u2013HCV coinfected patients with normal and elevated ALT. Dig Dis Sci 2011;56:3038\u20133044","journal-title":"Dig Dis Sci"},{"key":"9484_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2010.06.038","volume":"54","author":"T Poynard","year":"2011","unstructured":"Poynard T, Munteanu M, Colombo M, Bruix J, Schiff E, Terg R, et al. FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC(3) program. J Hepatol 2011;54:227\u2013235","journal-title":"J Hepatol"},{"key":"9484_CR21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cgh.2012.01.023","volume":"10","author":"T Poynard","year":"2012","unstructured":"Poynard T, Lenaour G, Vaillant JC, Capron F, Munteanu M, Eyraud D, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol 2012;10:657\u2013663","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9484_CR22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0168-8278(02)00211-8","volume":"37","author":"SS Lee","year":"2002","unstructured":"Lee SS, Heathcote EJ, Reddy KR, Zeuzem S, Fried MW, Wright TL, et al. Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD). J Hepatol 2002;37:500\u2013506","journal-title":"J Hepatol"},{"key":"9484_CR23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2010.04.013","volume":"139","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Muir AJ, Sulkowski MS, Ge D, Fellay J, Shianna KV, et al. Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in hepatitis C virus-1 patients. Gastroenterology 2010;139:120\u2013129","journal-title":"Gastroenterology"},{"key":"9484_CR24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.21159","volume":"43","author":"DM Jensen","year":"2006","unstructured":"Jensen DM, Morgan TR, Marcellin P, Pockros PJ, Reddy KR, Hadziyannis SJ, et al. Early identification of HCV genotype 1 patients responding to 24\u00a0weeks peginterferon alpha-2a (40 KD)\/ribavirin therapy. Hepatology 2006;43:954\u2013960","journal-title":"Hepatology"},{"key":"9484_CR25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1440-1746.2007.04904.x","volume":"22","author":"JW Yu","year":"2007","unstructured":"Yu JW, Wang GQ, Sun LJ, Li XG, Li SC. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin. J Gastroenterol Hepatol 2007;22:832\u2013836","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"9484_CR26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2010.10.032","volume":"55","author":"MW Fried","year":"2011","unstructured":"Fried MW, Hadziyannis SJ, Shiffman ML, Messinger D, Zeuzem S. Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection. J Hepatol 2011;55(1):69\u2013675","journal-title":"J Hepatol"},{"key":"9484_CR27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cgh.2010.07.019","volume":"9","author":"AF Stattermayer","year":"2011","unstructured":"Stattermayer AF, Stauber R, Hofer H, Rutter K, Beinhardt S, Scherzer TM, et al. Impact of IL28B genotype on the early and sustained virologic response in treatment-naive patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2011;9:344\u2013350","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9484_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2005.04.009","volume":"43","author":"P Ferenci","year":"2005","unstructured":"Ferenci P, Fried MW, Shiffman ML, Smith CI, Marinos G, Goncales FL Jr, et al. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)\/ribavirin. J Hepatol 2005;43:425\u2013433","journal-title":"J Hepatol"},{"key":"9484_CR29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.cgh.2011.03.002","volume":"9","author":"T Reiberger","year":"2011","unstructured":"Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, et al. Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clin Gastroenterol Hepatol 2011;9:602\u2013608","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9484_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2893.2012.01635.x","volume":"20","author":"N Tamaki","year":"2013","unstructured":"Tamaki N, Kurosaki M, Tanaka K, Suzuki Y, Hoshioka Y, Kato T, et al. Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C. J Viral Hepat 2013;20:72\u201376","journal-title":"J Viral Hepat"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9484-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-013-9484-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-013-9484-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:37:15Z","timestamp":1559432235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-013-9484-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["9484"],"URL":"https:\/\/doi.org\/10.1007\/s12072-013-9484-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,22]]}}}